Our Trustees

Our incredible board of trustees offer a wealth of knowledge and experience covering all aspects of Scleroderma and Raynaud's. Their expertise and unrivalled level of insight remain at the heart of the governance and guidance of everything we do at SRUK.

Chris Coombe

Chris is a qualified chartered accountant and brings over 30 years of financial experience to SRUK. He has lived and worked in various locations in the UK, Asia, Australia, the US and the Middle East. His business experience ranges from being a chief executive for a start-up to being the chief financial officer for Fidelity International, a global investment manager. This is his first venture into the voluntary sector and he is excited to have the opportunity to help to minimise the impact of Raynaud's and scleroderma on peoples' lives.

Jason Bryant

Jason’s career has been concentrated on the future of money and health, creating the next areas of growth for companies in those spaces.

His two decades of experience within Financial Services covers wealth management, retail banking and institutional banking. He has been a founder of his own digital startup and most recently led innovation labs in FinTech and HealthTech.

Jason is an Actuary and began his career that way, before morphing through change management, innovation, business transformation and digital transformation. He is an experienced and passionate practitioner of design thinking, lean startup and agile development and feels most inspired when collaborating with talented people to find breakthrough solutions to big problems.

His work has taken him from Sydney to New York and on to London. At home, Jason enjoys expanding his horizons and making music, especially with his daughters.

Dr Jitinder Saini

Jit’s background is in clinical medicine, having practiced gastroenterology and hepatology in the NHS for a number of years before joining the pharmaceutical sector. Jit has held various leadership roles in large biotech companies, including at executive board level, currently heading up Medical Affairs for Europe, Middle East and Africa for a global specialty innovator. Having just returned to the UK having lived in Switzerland, France and Germany, Jit is delighted to be able to serve as a trustee for SRUK and is grateful for the opportunity to serve patients through the important work of the charity.

Dorian Haskard

Dorian was a Consultant Rheumatologist at Hammersmith Hospital until he retired from clinical work in 2013. He is Professor of Cardiovascular Medicine and Rheumatology at Imperial College, a role that brings together his interests in rheumatic diseases and disorders of the vasculature. He established and convenes the Imperial College Network of Excellence in Vascular Science, which brings together around a hundred researchers from diverse clinical and non-clinical scientific disciplines. As a Trustee, he hopes to further the aims of the charity through a multidisciplinary approach to progress in Scleroderma and Raynaud’s.

Kellie Scott

Kellie has worked for Europe’s largest conservation charity for 16 years and is currently a senior leader in the organisation. Accountable for a wide-ranging portfolio, from land management to historic conservation, she also brings experience in people leadership (both staff and volunteers), supporter engagement and business planning. Kellie was diagnosed with Raynaud’s and scleroderma in 2016 and is proud to act as a patient trustee for SRUK.

Allan Lawrie

Allan has a background in scientific research for cardiovascular disease. He is Professor of Translational Cardiopulmonary Science and British Heart Foundation Senior Research Fellow at the University of Sheffield. He leads multi-disciplinary teams of clinical, basic and computational scientists investigating the mechanisms of pulmonary vascular disease and biomarkers to aid the identification of new therapeutic targets and treatment for the benefit of patients with Pulmonary Hypertension and associated conditions, including scleroderma.

Elliot Dunster

Elliot is Executive Director of Communications at IFPMA, the trade association representing the global pharmaceutical industry, in official relations with the United Nations.

Elliot has a background in advocacy, communications and policy development and he has led successful campaigns in the pharmaceutical industry and the voluntary sector over the past ten years. He was previously the Executive Director of Corporate Affairs and Devolved Nations at the UK pharmaceutical industry trade association, the ABPI and has experience leading a wide range of teams, including digital, brand, internal communications, policy, research, Government affairs and media.

Elliot's mother lived with scleroderma, Raynaud's and Lupus and he is committed to working as a trustee of SRUK to improve the lives of everyone affected by scleroderma and Raynaud's.

Jerry Donohue

Jerry joined SRUK as a Trustee in July 2021 and is thrilled to be able to contribute to such an important charity. He has over 30 years of financial and investing experience working in both the US and UK and is a Chartered Financial Analyst. His experience includes managing investment portfolios, social investing and helping small British businesses raise capital to grow. His previous experience includes AXA Investment Managers, FSE C.I.C. and GE Capital. While this is his first trustee role for a charity, he has been active in local arts and community organisations and spent many years as a commissioner for LondonSports which runs basketball, baseball and softball programmes for local children